Lewes, DE -- (SBWIRE) -- 09/16/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: OncoSec Medical Inc(OTCMKTS:ONCS), Advanced Cell Technology, Inc.(OTCBB:ACTC), NanoTech Entertainment, Inc.(OTCMKTS:NTEK), Amarantus Bioscience Holdings, Inc (OTCBB:AMBS)
OncoSec Medical Inc(OTCMKTS:ONCS) ended higher +8.11% and complete the day at $0.320. The total number of shares changed hands during the day was 1.47 million. After opening at $0.29, the stock hit as high as $0.34. However, it traded between $0.18 and $0.49 over the last twelve months.
OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology
For How Long ONCS will Fight for Profitability? Read This Trend Analysis report
Advanced Cell Technology, Inc.(OTCBB:ACTC) closed yesterday at $0.0625, a +2.46% increase. Around 6.60 million shares were traded, low from an-average trading volume of 10.18 million shares. The company is now valued at around $160.25 million.
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine
For How Long ACTC Gloss will Attract Investors? Find out via this report
NanoTech Entertainment, Inc.(OTCMKTS:NTEK) moved -2.93 percent lower at $0.0895 and traded between $0.08 and $0.09 after opening the day at $0.09. Its performance over the last five days remained 14.01%, which stands at 54.31% for a month. Going back further than one month, 1-year performance after recent close was 5493.75%.
NanoTech Entertainment, Inc. operates as a technology company with focus on entertainment industry worldwide. The company virtual manufactures and develops technology and games, and then licenses to coin-op arcade, casino gaming, and consumer gaming markets
Why Should Investors Buy NTEK After the Recent Fall? Just Go Here and Find Out
Amarantus Bioscience Holdings, Inc (OTCBB:AMBS) shares fall, losing -6.17 percent to close at $0.0699. Around 4.45 million shares changed hands yesterday.
Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Will AMBS Get Buyers Even After The Recent Rally? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/